Judith J. Zwart-Gout
Groningen, GR 9713GH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands.
Journal: PharmacoEconomics - open
Published: September 20, 2019
Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands: a real-world data based cost-effectiveness analysis.
Journal: Journal of medical economics
Published: January 08, 2019
Trends in direct oral anticoagulant (DOAC) use: health benefits and patient preference.
Journal: The Netherlands journal of medicine
Published: December 21, 2018
Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related Hospitalizations.
Journal: Applied health economics and health policy
Published: September 04, 2018
Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: January 30, 2018
Further approaches to reduce the cost of renal replacement therapy.
Journal: Nature reviews. Nephrology
Published: September 26, 2017
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.
Journal: Nature reviews. Nephrology
Published: May 31, 2017
A Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline Pharmacotherapy.
Journal: PloS one
Published: February 12, 2016
Comparative Cost-Effectiveness of Drugs in Early versus Late Stages of Cancer; Review of the Literature and a Case Study in Breast Cancer.
Journal: PloS one
Published: June 28, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026